Related Experiment Video
Updated: Feb 12, 2026
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
1.3K
Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery
Pier G De Benedetti1, Francesca Fanelli2
1Department of Life Sciences, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy.
Drug Discovery Today
|March 26, 2018
Summary
Quantitative structure-kinetics relationship (QSKR) models reveal that kinetic rates and binding affinity are crucial for drug design. Understanding these relationships aids in optimizing drug-target interactions and predicting drug efficacy.
Area of Science:
- Computational chemistry
- Medicinal chemistry
- Pharmacology
Background:
- Drug design and discovery rely on understanding molecular interactions.
- Kinetic rates and binding affinity are key parameters influencing drug efficacy.
- Quantitative Structure-Activity Relationship (QSAR) and related modeling approaches are vital tools.
Purpose of the Study:
- To explore the interplay between kinetic rates and binding affinity in drug design.
- To discuss the significance of molecular series selection in quantitative structure-kinetics relationship (QSKR) modeling.
- To examine the implications of linear correlations between kinetic rates and binding affinity constants.
Main Methods:
- Comparative correlation analyses.
- Development and application of quantitative structure-kinetics relationship (QSKR) models.
- Analysis of ligand and/or drug-target binding and unbinding processes.
Main Results:
- QSKR models underscore the essential role of kinetic rates and binding affinity in drug design.
- The selection of molecular series significantly impacts the mechanistic insights derived from QSKR modeling.
- Linear correlations between kinetic rates and binding affinity constants provide valuable information.
Conclusions:
- Understanding the relationship between kinetics and affinity is fundamental for effective drug discovery.
- Computational approaches, particularly QSKR, are relevant for mechanistic drug-target interaction studies.
- Careful selection of molecular data is critical for successful QSKR model development and interpretation.
More Related Videos
Related Concept Videos
01:16Protein-Drug Binding: Mechanism and Kinetics
1.9K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.9K
01:28Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
01:26Drug Discovery: Overview
11.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.9K
01:17Kinetics of Drug Elimination
4.2K
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
4.2K
01:49Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
492
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
492